Vincenzo Ronca of September 21, 2023, 00:12
For years we have known the immense resources that Elon Musk invests in the fields of technology and medicine. In addition to electric cars and interest in space, we know in fact Neuralinkthe device development company implantable in the brain.
In the last few hours they have emerged important developments from Neuralink, as the company announced it had applications open to be part of first study on humans of the chip implantable in the brain. This means that for the first time this device will actually be implanted and activated in a human brain.
Read also:
Galaxy S24 Ultra will not have 10x optical zoom, a big mistake?
Galaxy S24 Ultra will not have 10x optical zoom, a big mistake?
Androidworld
 > 
Neuralink has made it known that it is looking for people with quadriplegia due to vertical lesion of the spinal cord or ALSand that they have more than 22 years and a reliable caregiver, given that the assistant figure would also become part of the study.
The study in question is called Precise Robotically Implanted Brain-Computer Interface (PRIME) and has the objective of test three components main features of the system developed by Neuralink: the N1 plant, the device that interfaces the brain with the Neuralink computer; the second is the R1 robot, the surgical robot that actually implants the device; the third is the N1 User Appthe software that connects to the N1 and translates brain signals into computer actions.
Neuralink says it plans to test both the safety That effectiveness of all three parts of the system.
In any case, it is a device that has the objective of dramatically improve lives of sick patients, who are unable to move or even express themselves, although their brain is normally able to generate all the impulses necessary to carry out actions or verbal expressions.
The study that should start would have the duration of 6 yearsand we always expect a Neuralink release after that more accessible to everyone those who need it.
medicine
Neuralink
neuroscience
Show comments
